logo-loader
NYSE:AIM

AIM ImmunoTech Inc

Receive alerts
Market:
NYSE
Price
0.45 USD
Day Change
3.75%
Market Cap:
$21.78 m
52 weeks high
0.72
52 weeks low
0.33

In brief

AIM ImmunoTech Inc. is an immuno-pharma company headquartered in Ocala, Florida and focused on the research and development of therapeutics to treat multiple types of cancers, as well as immune-deficiency disorders. It has established a strong foundation of laboratory, pre-clinical and clinical data with respect to the development of nucleic acids and natural interferon to enhance the natural antiviral defense system of the human body and to aid the development of therapeutic products for the treatment of certain cancers and chronic diseases.